tiprankstipranks
Trending News
More News >
Sumitomo Dainippon Pharma Co Ltd (DNPUF)
OTHER OTC:DNPUF
US Market

Sumitomo Dainippon Pharma Co (DNPUF) Income Statement

Compare
9 Followers

Sumitomo Dainippon Pharma Co Income Statement

Last quarter (Q2 2026), Sumitomo Dainippon Pharma Co's total revenue was ¥119.12B, an increase of 32.25% from the same quarter last year. In Q2, Sumitomo Dainippon Pharma Co's net income was ¥87.65B. See Sumitomo Dainippon Pharma Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 398.83B¥ 314.56B¥ 555.54B¥ 560.03B¥ 515.95B
Gross Profit
¥ 245.40B¥ 187.98B¥ 376.63B¥ 402.91B¥ 378.18B
Operating Expenses
¥ 216.59B¥ 542.17B¥ 331.74B¥ 342.67B¥ 306.95B
Depreciation and Amortization
¥ 25.56B¥ 37.77B¥ 41.26B¥ 38.35B¥ 22.67B
EBITDA
¥ 56.67B¥ -281.07B¥ -3.50B¥ 124.36B¥ 103.11B
Operating Income
¥ 28.80B¥ -354.19B¥ -76.98B¥ 60.23B¥ 71.22B
Other Income/Expenses
¥ -11.19B¥ 31.08B¥ 29.06B¥ 22.73B¥ 6.63B
Pretax Income
¥ 17.61B¥ -323.11B¥ -47.92B¥ 82.96B¥ 77.85B
Net Income
¥ 23.63B¥ -314.97B¥ -74.51B¥ 56.41B¥ 56.22B
Per Share Metrics
Basic EPS
¥ 59.49¥ -792.79¥ -187.55¥ 141.99¥ 141.50
Diluted EPS
¥ 59.49¥ -792.79¥ -187.55¥ 141.99¥ 141.50
Weighted Average Shares Outstanding
397.29M 397.29M 397.29M 397.29M 397.29M
Weighted Average Shares Outstanding (Diluted)
397.29M 397.29M 397.29M 397.29M 397.29M
Currency in JPY

Sumitomo Dainippon Pharma Co Earnings and Revenue History